Principal Exchange-Traded Funds Principal Healthcare Innovators ETF
BTEC
BTEC was delisted on the 31st of July, 2024.
0 hedge funds and large institutions have $0 invested in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 20 closing their positions.
100% less funds holding
Funds holding: 20 → 0 (-20)
100% less capital invested
Capital invested by funds: $2.89M → $0 (-$2.89M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 20
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$713K |
| 2 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
-$412K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$378K |
| 4 |
Morgan Stanley
New York
|
-$305K |
| 5 |
PS
Principal Securities
Des Moines,
Iowa
|
-$239K |
BTEC Hedge Fund Activity: Q3 2024 in Review
0 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) for Q3 2024, worth a combined $0 — down 100% from $2.89M a quarter earlier.
Sellers outnumbered buyers: 20 funds closed out of BTEC and 0 opened new positions — a net loss of 20 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Citadel Advisors, exiting entirely with an estimated $713K sold.
- 0 institutional investors held Principal Exchange-Traded Funds Principal Healthcare Innovators ETF (BTEC) as of Q3 2024, down from 20 in Q2 2024.
- Funds reported $0 of Principal Exchange-Traded Funds Principal Healthcare Innovators ETF stock for Q3 2024, down 100% quarter-over-quarter.
- 0 funds opened new Principal Exchange-Traded Funds Principal Healthcare Innovators ETF positions in Q3 2024 and 20 closed out, a net change of -20 holders.
- The largest Principal Exchange-Traded Funds Principal Healthcare Innovators ETF seller in Q3 2024 was Citadel Advisors, an estimated $713K sold.
Based on aggregated 13F filings for Q3 2024.